Ami Organics Limited
Book Built Issue IPO · NSE, BSE
- Price band
- ₹603 - 610
- Lot size
- 24 shares
- Issue amount
- ₹570 cr
- Total subscription
- 0×
- Opens
- 1 Sept 2021
- Closes
- 3 Sept 2021
- Allotment
- 8 Sept 2021
- Listing
- 14 Sept 2021
Offer at a glance
Issue overview
- Issue size
- 93,38,288 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹14,472
- Fresh issue
- ₹200 cr
- Offer for sale
- ₹370 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,640
- Issue type
- Book Built Issue IPO
- Shares before issue
- 3,31,58,374
- Shares after issue
- 3,64,37,063
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 24 | ₹14,640 |
| sHNI | 14 | 336 | ₹2,04,960 |
| bHNI | 69 | 1,656 | ₹10,10,160 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2004, Ami Organics Limited is a research-driven manufacturer of specialty chemicals, producing advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs) for new chemical entities, and materials for agrochemicals and fine chemicals. The company has developed over 450 pharma intermediates across 17 therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant, supplying more than 150 domestic and international customers across 25 countries, including Europe, the USA, China, Israel, Japan, and Latin America. Its manufacturing operations are based in Gujarat at Sachin, Ankleshwar, and Jhagadia, with a combined installed capacity of 6,060 MTPA.
Strengths
- Leading Manufacturer: Produces key pharma intermediates like Dolutegravir, Trazodone, Entacapone, Nintedanib, and Rivaroxaban.
- Diversified Portfolio: Offers 450+ pharma intermediates across 17 therapeutic areas.
- Wide Presence: Extensive geographic reach with a diverse customer base.
- Strong Capabilities: Robust R&D, sales, and marketing expertise.
- Consistent Financials: Demonstrates a reliable track record of financial performance.
Promoters
Nareshkumar Ramjibhai Patel
Chetankumar Chhaganlal Vaghasia
Shital Nareshbhai Patel
Parul Chetankumar Vaghasia
Registrar & documents
Lead manager
Ambit Private Limited, Axis Capital Limited, Intensive Fiscal Services Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. 440/4, 5 & 6, Road No. 82/A GIDC Sachin, Surat – 394 230
+91 261 239 7193
[email protected]Company website ↗Understanding AMIORG IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.